[1]
“Pharmacoeconomic analysis of type 2 diabetes mellitus and its microvascular complications”, Int J Res Pharm Hos & Clin. Pharm, vol. 1, no. 1, pp. 11–14, Mar. 2024, Accessed: Apr. 18, 2025. [Online]. Available: https://rubatosis.org/journals/index.php/ijrhcp/article/view/122